Drug maker halts early safety test on healthy volunteers
NCT ID NCT07039929
Summary
This early-stage study aimed to check the safety and see how the body processes a new oral drug called INCB000631. It involved 24 healthy adults who received either the drug or a placebo. The main goals were to find safe dose levels and measure how much of the drug gets into the bloodstream and how long it stays.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celerion, Inc
Lincoln, Nebraska, 68502, United States
Conditions
Explore the condition pages connected to this study.